Biomaterial considerations for drug-eluting stents

Proceedings of the 31st Annual International Conference of the IEEE Engineering in Medicine and Biology Society: Engineering the Future of Biomedicine, EMBC 2009

Volumn , Issue , 2009, Pages 2416-2417

  Parsonage, Ed ^a   Girton, Tim ^a   Knapp, David ^a  

^a BOSTON SCIENTIFIC CORPORATION   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ARTIFICIAL ORGANS; BIOMATERIALS;

BOSTON SCIENTIFIC; CLINICAL EVALUATION; DEVELOPMENT PROCESS; DRUG-ELUTING STENTS; END POINTS; INITIAL DESIGN; PRODUCT PERFORMANCE;

STENTS;

EID: 77951020596     PISSN: None     EISSN: None     Source Type: Conference Proceeding    
DOI: 10.1109/IEMBS.2009.5335396     Document Type: Conference Paper

References (5)

1. K. R. Kamath, J. J. Barry, K. M. Miller, "The TAXUS(TM) drug-eluting stent: A new paradigm in controlled drug delivery," Advanced Drug Delivery Reviews. pp. 421-437, June 2006
2. G. Acharya, K. Park, "Mechanisms of controlled drug release from drug-eluting stents," Advanced Drug Delivery Reviews, pp. 387-402, June 2006.
3. V. Barocas, W. Drassler II, T. Girton, I. Guler, D. Knapp, J. Moeller, E. Parsonage, " A dissolution diffusion model for TAXUS™ drug eluting stent with surface burst estimated from continuum percolation,", in press.
4. R. S. Schwartz, E. R. Edelman, A. Carter, N. Chronos, C. Rogers, K. A. Robinson, R. Waksman J. Weinberger, R. L. Wilensky, D. N. Jensen, B. D. Zuckerman, R. Virmani, "Drug-eluting stents in preclinical studies: recommended evaluation from a consensus group," Circulation Vol 106(14), pp.1867-1873, 2002
5. P. S. Seifert, B. A. Huibregtse, J. Polovick, B. Poff, "Early vascular response to overlapped paclitaxel-eluting stents in swine coronary arteries," in Cardiovascular Revascularization Medicine, Vol 8, 2007, pp. 251-258